These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8990246)

  • 1. Measurement of maternal folate status and risk of neural tube defects.
    Makowski GS; Hopfer SM
    Clin Chem; 1997 Jan; 43(1):185-6. PubMed ID: 8990246
    [No Abstract]   [Full Text] [Related]  

  • 2. Maternal folate status and risk of neural tube defects.
    Kirke PN; Daly LE; Molloy A; Weir DG; Scott JM
    Lancet; 1996 Jul; 348(9019):67-8. PubMed ID: 8691964
    [No Abstract]   [Full Text] [Related]  

  • 3. Is 5-methyltetrahydrofolate an alternative to folic acid for the prevention of neural tube defects?
    Obeid R; Holzgreve W; Pietrzik K
    J Perinat Med; 2013 Sep; 41(5):469-83. PubMed ID: 23482308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folate and vitamin B12 concentrations in maternal and fetal blood, and amniotic fluid in second trimester pregnancies complicated by neural tube defects.
    Economides DL; Ferguson J; Mackenzie IZ; Darley J; Ware II; Holmes-Siedle M
    Br J Obstet Gynaecol; 1992 Jan; 99(1):23-5. PubMed ID: 1547166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood folic acid and vitamin B12 in relation to neural tube defects.
    Wald NJ; Hackshaw AD; Stone R; Sourial NA
    Br J Obstet Gynaecol; 1996 Apr; 103(4):319-24. PubMed ID: 8605127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma folate levels and associated factors in women planning to become pregnant in a population with high prevalence of neural tube defects.
    Ma R; Wang L; Jin L; Li Z; Ren A
    Birth Defects Res; 2017 Jul; 109(13):1039-1047. PubMed ID: 28569432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies against homocysteinylated protein in a mouse model of folate deficiency-induced neural tube defects.
    Denny KJ; Kelly CF; Kumar V; Witham KL; Cabrera RM; Finnell RH; Taylor SM; Jeanes A; Woodruff TM
    Birth Defects Res A Clin Mol Teratol; 2016 Mar; 106(3):201-7. PubMed ID: 26900104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid and primary prevention of neural tube defects: A review.
    van Gool JD; Hirche H; Lax H; De Schaepdrijver L
    Reprod Toxicol; 2018 Sep; 80():73-84. PubMed ID: 29777755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum folate by two methods in pregnant women carrying fetuses with neural tube defects.
    Thame G; Guerra-Shinohara EM; Moron AF
    Clin Chem; 2002 Jul; 48(7):1094-5. PubMed ID: 12089179
    [No Abstract]   [Full Text] [Related]  

  • 10. Maternal and fetal serum and red blood cell folate and vitamin B12 concentrations in pregnancies affected by neural tube defects.
    Thorand B; Pietrzik K; Prinz-Langenohl R; Hages M; Holzgreve W
    Z Geburtshilfe Neonatol; 1996; 200(5):176-80. PubMed ID: 8950836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of Folic Acid Fortified Flour for Prevention of Neural Tube Defects in a High Risk Region.
    Wang H; De Steur H; Chen G; Zhang X; Pei L; Gellynck X; Zheng X
    Nutrients; 2016 Mar; 8(3):152. PubMed ID: 27005659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of folic acid pharmacokinetics in obese and nonobese women of childbearing age.
    Stern SJ; Matok I; Kapur B; Koren G
    Ther Drug Monit; 2011 Jun; 33(3):336-40. PubMed ID: 21572389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological differences in folate/vitamin B12 in pregnancies affected by neural tube defects.
    Cech I; Burau KD
    South Med J; 2010 May; 103(5):419-24. PubMed ID: 20375932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal serum folate and vitamin B12 concentrations in pregnancies associated with neural tube defects.
    Molloy AM; Kirke P; Hillary I; Weir DG; Scott JM
    Arch Dis Child; 1985 Jul; 60(7):660-5. PubMed ID: 4026363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of serum folate, 25-OH vitamin D, and calcium levels between pregnants with and without fetal anomaly of neural tube origin.
    Sirinoglu HA; Pakay K; Aksoy M; Bakırci IT; Ozkaya E; Sanverdi I
    J Matern Fetal Neonatal Med; 2018 Jun; 31(11):1490-1493. PubMed ID: 28420274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of maternal homocysteine and vitamins status with the risk of neural tube defects in Tunisia: A case-control study.
    Nasri K; Ben Fradj MK; Touati A; Aloui M; Ben Jemaa N; Masmoudi A; Elmay MV; Omar S; Feki M; Kaabechi N; Marrakchi R; Gaigi SS
    Birth Defects Res A Clin Mol Teratol; 2015 Dec; 103(12):1011-20. PubMed ID: 26386249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The levels of vitamın B12, folate and homocysteine in mothers and their babies with neural tube defects.
    Peker E; Demir N; Tuncer O; Üstyol L; Balahoroğlu R; Kaba S; Karaman K
    J Matern Fetal Neonatal Med; 2016 Sep; 29(18):2944-8. PubMed ID: 26479326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plasma and red blood cell folate levels among women in their first trimester of pregnancy from rural areas with high or low prevalence of neural tube defects, China].
    Zhang L; Ren AG; Li ZW; Hao L; Tian YH; Li Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Aug; 27(8):659-63. PubMed ID: 17172103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid supplementation: more work is needed.
    Björklund NK; Evans JA; Greenberg CR
    CMAJ; 2000 Oct; 163(9):1129-30. PubMed ID: 11079054
    [No Abstract]   [Full Text] [Related]  

  • 20. Periconceptional folic acid supplementation: a new indication for therapeutic drug monitoring.
    Tam C; McKenna K; Goh YI; Klieger-Grossman C; O'Connor DL; Einarson A; Koren G
    Ther Drug Monit; 2009 Jun; 31(3):319-26. PubMed ID: 19349928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.